Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with reduced-size liver transplantation.

M Kalayoglu1, A M D'Alessandro, H W Sollinger

  • 1Department of Surgery, School of Medicine, University of Wisconsin, Madison.

Surgery, Gynecology & Obstetrics
|August 1, 1990
PubMed
Summary

Reduced-size liver transplants (RLT) offer a viable solution for pediatric liver disease, demonstrating survival rates comparable to full-size grafts. This approach expands donor organ availability, reducing waitlist mortality for children needing liver transplants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting Donor Death: Early Changes in Oxygen Saturation After Withdrawal of Support Predict Successful Donation During Donation After Circulatory Death.

Transplantation proceedings·2016
Same author

Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

The impact of social, cognitive and attitudinal dimensions on college students' support for organ donation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

A hierarchical communication model of the antecedents of health care professionals' support for donations after cardiac death.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Possible involvement of advanced glycation end products in periodontal diseases.

International journal of immunopathology and pharmacology·2010

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Pediatric Gastroenterology

Background:

  • Limited availability of size-matched donor organs poses a challenge for pediatric liver transplantation.
  • Reduced-size liver transplants (RLT) are proposed to increase donor organ pool and decrease waitlist mortality.

Purpose of the Study:

  • To evaluate the efficacy and patient survival rates of reduced-size liver transplants (RLT) in pediatric patients.
  • To assess the feasibility of RLT as an alternative to full-size grafts for end-stage liver disease in children.

Main Methods:

  • A retrospective analysis of 15 RLT procedures performed on 12 pediatric patients between May 1988 and April 1989.
  • Grafts included left lobe and extended right lobe segments, preserved using University of Wisconsin solution.

Related Experiment Videos

Main Results:

  • The mean donor to recipient ratio was 9.0:1.0.
  • Graft and extrahepatic complications occurred in 4 and 5 patients, respectively.
  • An 83% patient survival rate was observed at a mean follow-up of 6.7 months, with successful retransplantation in 3 of 4 cases.

Conclusions:

  • Patient survival with RLT is comparable to full-size liver grafting.
  • RLT should be considered an acceptable therapy for pediatric end-stage liver disease.
  • Elective application of RLT may further improve patient survival outcomes.